Mathieu Bourdenx

7.0k total citations · 3 hit papers
32 papers, 2.2k citations indexed

About

Mathieu Bourdenx is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Mathieu Bourdenx has authored 32 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 13 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Mathieu Bourdenx's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Mathieu Bourdenx is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Mathieu Bourdenx collaborates with scholars based in France, United States and United Kingdom. Mathieu Bourdenx's co-authors include Benjamin Dehay, Erwan Bézard, Ana María Cuervo, Olatz Pampliega, Aurora Scrivo, Wassilios G. Meissner, Federico N. Soria, Miquel Vila, Stéphane Hunot and Serge Przedborski and has published in prestigious journals such as Neuron, Molecular Cell and Nature Cell Biology.

In The Last Decade

Mathieu Bourdenx

32 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

2015 388 citations Benjamin Dehay, Mathieu Bourdenx et al. The Lancet Neurology profile →
The different autophagy degradation pathways and neurodegeneration

2022 293 citations Angeleen Fleming, Mathieu Bourdenx et al. Neuron profile →
Selective autophagy as a potential therapeutic target for neurodegenerative disorders

2018 276 citations Aurora Scrivo, Mathieu Bourdenx et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathieu Bourdenx France	21	822	725	679	631	437	32	2.2k
Salvatore J. Cherra United States	14	1.1k 1.3×	838 1.2×	929 1.4×	483 0.8×	364 0.8×	20	2.1k
Cristina Malagelada Spain	22	1.1k 1.4×	633 0.9×	456 0.7×	321 0.5×	599 1.4×	37	2.2k
Heather Mortiboys United Kingdom	26	1.4k 1.7×	1.2k 1.7×	566 0.8×	671 1.1×	559 1.3×	48	2.7k
Elena Ziviani Italy	22	1.3k 1.6×	692 1.0×	873 1.3×	409 0.6×	400 0.9×	32	2.0k
Cristòfol Vives-Bauzá United States	19	1.5k 1.8×	785 1.1×	1.0k 1.5×	410 0.6×	369 0.8×	36	2.5k
Melissa Nassif Chile	23	568 0.7×	697 1.0×	796 1.2×	329 0.5×	332 0.8×	37	1.9k
Tomohiro Kabuta Japan	26	1.1k 1.4×	625 0.9×	713 1.1×	351 0.6×	245 0.6×	55	2.2k
J. Alex Parker Canada	25	1.3k 1.6×	670 0.9×	290 0.4×	494 0.8×	578 1.3×	51	2.5k
Nicoletta Plotegher Italy	22	844 1.0×	982 1.4×	243 0.4×	635 1.0×	451 1.0×	38	2.0k
Jin H. Son United States	26	1.1k 1.3×	497 0.7×	469 0.7×	327 0.5×	751 1.7×	60	2.4k

Countries citing papers authored by Mathieu Bourdenx

Since Specialization

Citations

This map shows the geographic impact of Mathieu Bourdenx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bourdenx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bourdenx more than expected).

Fields of papers citing papers by Mathieu Bourdenx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Bourdenx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bourdenx. The network helps show where Mathieu Bourdenx may publish in the future.

Co-authorship network of co-authors of Mathieu Bourdenx

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Bourdenx. A scholar is included among the top collaborators of Mathieu Bourdenx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Bourdenx. Mathieu Bourdenx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Das, Debajyoti, Mridul Sharma, Z. Hong Zhou, et al.. (2024). VPS4A is the selective receptor for lipophagy in mice and humans. Molecular Cell. 84(22). 4436–4453.e8. 10 indexed citations

Rajani, Rikesh M., Sam Harris, David Graykowski, et al.. (2024). Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease. PLoS Biology. 22(7). e3002727–e3002727. 21 indexed citations

Doveró, Sandra, Mathieu Bourdenx, Marie-Laure Arotçarena, et al.. (2023). Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain. npj Parkinson s Disease. 9(1). 135–135. 6 indexed citations

Zhu, Tao, Li Zhou, Xianglei Li, et al.. (2023). Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric‐Aβ mediates pathology maturation. Alzheimer s & Dementia. 20(3). 1894–1912. 19 indexed citations

Martínez-López, Nuria, Pamela Mattar, Míriam Toledo, et al.. (2023). mTORC2–NDRG1–CDC42 axis couples fasting to mitochondrial fission. Nature Cell Biology. 25(7). 989–1003. 25 indexed citations

Fleming, Angeleen, Mathieu Bourdenx, Motoki Fujimaki, et al.. (2022). The different autophagy degradation pathways and neurodegeneration. Neuron. 110(6). 935–966. 293 indexed citations breakdown →

Bourdenx, Mathieu, Evripidis Gavathiotis, & Ana María Cuervo. (2021). Chaperone-mediated autophagy: a gatekeeper of neuronal proteostasis. Autophagy. 17(8). 2040–2042. 36 indexed citations

Juste, Yves R., Susmita Kaushik, Mathieu Bourdenx, et al.. (2021). Reciprocal regulation of chaperone-mediated autophagy and the circadian clock. Nature Cell Biology. 23(12). 1255–1270. 51 indexed citations

Monday, Hannah R., Mathieu Bourdenx, Bryen A. Jordan, & Pablo E. Castillo. (2020). CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination. eLife. 9. 21 indexed citations

10.

Kirchner, Philipp, Mathieu Bourdenx, Julio Madrigal‐Matute, et al.. (2019). Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. PLoS Biology. 17(5). e3000301–e3000301. 162 indexed citations

11.

Bourdenx, Mathieu, Sandra Doveró, Marie-Laure Thiolat, Erwan Bézard, & Benjamin Dehay. (2017). Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model. Scientific Reports. 7(1). 45831–45831. 21 indexed citations

12.

Bastide, Matthieu F., Christelle Glangetas, Évelyne Doudnikoff, et al.. (2017). Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia. Scientific Reports. 7(1). 2348–2348. 6 indexed citations

13.

Bourdenx, Mathieu, Jonathan Daniel, Emilie Génin, et al.. (2016). Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases. Autophagy. 12(3). 472–483. 160 indexed citations

14.

Bourdenx, Mathieu & Benjamin Dehay. (2016). What lysosomes actually tell us about Parkinson’s disease?. Ageing Research Reviews. 32. 140–149. 22 indexed citations

15.

Dehay, Benjamin, Mathieu Bourdenx, Philippe Gorry, et al.. (2015). Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations. The Lancet Neurology. 14(8). 855–866. 388 indexed citations breakdown →

16.

Bourdenx, Mathieu, Benjamin Dehay, & Erwan Bézard. (2015). Modélisation expérimentale de l’agrégation et de la propagation de l’α-synucléine dans les synucléinopathies. Bulletin de l Académie Nationale de Médecine. 199(6). 797–808. 3 indexed citations

17.

Barroso‐Chinea, Pedro, Marie-Laure Thiolat, Simone Bido, et al.. (2015). D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly. Neurobiology of Disease. 78. 77–87. 11 indexed citations

18.

Bourdenx, Mathieu, Nikolaos Stavros Koulakiotis, Despina Sanoudou, et al.. (2015). Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies. Progress in Neurobiology. 155. 171–193. 143 indexed citations

19.

Engeln, Michel, Matthieu F. Bastide, Estelle Toulmé, et al.. (2014). Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA–Induced Dyskinesia. Biological Psychiatry. 79(5). 354–361. 64 indexed citations

20.

Bourdenx, Mathieu, Erwan Bézard, & Benjamin Dehay. (2014). Lysosomes and Î±-synuclein form a dangerous duet leading to neuronal cell death. Frontiers in Neuroanatomy. 8. 83–83. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact